Encapsulation of the HSP-90 Chaperone Inhibitor 17-AAG in Stable Liposome Allow Increasing the Therapeutic Index as Assessed, in vitro, on Leishmania (L) amazonensis Amastigotes-Hosted in Mouse CBA Macrophages-Reference-Cited by-同舟云学术

Encapsulation of the HSP-90 Chaperone Inhibitor 17-AAG in Stable Liposome Allow Increasing the Therapeutic Index as Assessed, in vitro, on Leishmania (L) amazonensis Amastigotes-Hosted in Mouse CBA Macrophages

Published:2018-08-30 Issue: Volume:8 Page:
ISSN:2235-2988
Container-title:Frontiers in Cellular and Infection Microbiology
language:
Short-container-title:Front. Cell. Infect. Microbiol.

Author:

Petersen Antonio Luis de Oliveira Almeida,Campos Thiers A.,Dantas Diana Angélica dos Santos,Rebouças Juliana de Souza,da Silva Juliana Cruz,de Menezes Juliana P. B.,Formiga Fábio R.,de Melo Janaina V.,Machado Giovanna,Veras Patrícia S. T.

Funder

Fundação de Amparo à Pesquisa do Estado da Bahia

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Frontiers Media SA

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference53 articles.

1. Cyclodextrin-poly(anhydride) nanoparticles as new vehicles for oral drug delivery;Agueros;Expert. Opin. Drug Deliv,2011

2. Liposome: classification, preparation, and applications;Akbarzadeh;Nanoscale Res. Lett,2013

3. Leishmaniasis worldwide and global estimates of its incidence;Alvar;PLoS ONE,2012

4. Leishmaniasis and poverty;Alvar;Trends Parasitol,2006

5. Liposome as drug carriers;Anwekar;Int. J. Pharm. Life Sci,2011

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of periodontal disease: does drug delivery matter?;Frontiers in Bioengineering and Biotechnology;2024-07-16

2. Pharmacokinetics, Dose-Proportionality, and Tolerability of Intravenous Tanespimycin (17-AAG) in Single and Multiple Doses in Dogs: A Potential Novel Treatment for Canine Visceral Leishmaniasis;Pharmaceuticals;2024-06-11

3. Development of solid lipid nanoparticles-loaded drugs in parasitic diseases;Discover Nano;2024-01-04

4. Heat Shock Proteins as Emerging Therapeutic and Vaccine Targets Against Leishmaniasis;Challenges and Solutions Against Visceral Leishmaniasis;2023

5. Virulence factors of Leishmania parasite: Their paramount importance in unraveling novel vaccine candidates and therapeutic targets;Life Sciences;2022-10